PTN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsPTN Upcoming Earnings Report: What to Expect?
2M ago
Palatin provides update on its clinical programs
Premium
The Fly
Palatin provides update on its clinical programs
2M ago
Palatin: FDA confirms acceptability of Phase 3 pivotal clinical trials for PL964
Premium
The Fly
Palatin: FDA confirms acceptability of Phase 3 pivotal clinical trials for PL964
2M ago
Palatin initiates Phase 2 clinical study of bremelanotide
PremiumThe FlyPalatin initiates Phase 2 clinical study of bremelanotide
5M ago
Palatin announces initiation of Phase 2 clinical study of bremelanotide
Premium
The Fly
Palatin announces initiation of Phase 2 clinical study of bremelanotide
5M ago
Palatin reports Q3 EPS (53c), consensus (50c)
Premium
The Fly
Palatin reports Q3 EPS (53c), consensus (50c)
6M ago
Palatin presents results from Phase 3 PL9643 MELODY-1 trial
PremiumThe FlyPalatin presents results from Phase 3 PL9643 MELODY-1 trial
7M ago
Palatin files to sell 1.92M shares of common stock for holders
Premium
The Fly
Palatin files to sell 1.92M shares of common stock for holders
8M ago
Palatin price target lowered to $17 from $70 at H.C. Wainwright
Premium
The Fly
Palatin price target lowered to $17 from $70 at H.C. Wainwright
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100